Gene · 3925
Papers4,446
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 4,446
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell and multi-omics analysis reveals the role of stem cells in prognosis and immunotherapy of lung adenocarcinoma patients. | Front Immunol | 2025 | 40766320 | PubTator, text mining | PubMed |
| A novel bispecific aptamer targeting LAG3 and HER2 enhances T cell-mediated immunotherapy against HER2-positive cancer cells. | Front Immunol | 2025 | 40761795 | PubTator, text mining | PubMed |
| Unraveling NK cell heterogeneity through single-cell sequencing: insights from physiological and tumor contexts for clinical applications. | Front Immunol | 2025 | 40761786 | PubTator, text mining | PubMed |
| Dynamic crosstalk between HSCs and liver microenvironment: multicellular interactions in the regulation of liver fibrosis. | Front Cell Dev Biol | 2025 | 40761743 | PubTator, text mining | PubMed |
| Flexible Distributed Lag Models for Count Data Using mgcv. | Am Stat | 2025 | 40747491 | PubTator, text mining | PubMed |
| METTL9 sustains vertebrate neural development primarily via non-catalytic functions. | Nat Commun | 2025 | 40745158 | PubTator, text mining | PubMed |
| CqStathmin negatively regulates white spot syndrome virus infection by destabilizing microtubules in Cherax quadricarinatus. | Dev Comp Immunol | 2025 | 40744386 | PubTator, text mining | PubMed |
| Polyploid giant cancer cells and tumor budding: translation from basic research to clinical application. | Front Oncol | 2025 | 40740858 | PubTator, text mining | PubMed |
| Current Advances in Classification, Prediction and Management of Microvascular Invasion in Hepatocellular Carcinoma. | J Cell Mol Med | 2025 | 40736417 | PubTator, text mining | PubMed |
| Human adult hippocampal neurogenesis in health and disease. | Aging Brain | 2025 | 40735066 | PubTator, text mining | PubMed |
| Stathmin Serine 16 Phosphorylation Is a Key Regulator of Cell Cycle Progression Without Activating Migration and Invasion In Vitro. | Cancers (Basel) | 2025 | 40723207 | PubTator, text mining | PubMed |
| Molecular Remodeling of the Sperm Proteome Following Varicocele Sclero-Embolization: Implications for Semen Quality Improvement. | Proteomes | 2025 | 40700278 | PubTator, text mining | PubMed |
| iVAE: an interpretable representation learning framework enhances clustering performance for single-cell data. | BMC Biol | 2025 | 40660220 | PubTator, text mining | PubMed |
| Identification of prognostic biomarkers related to epithelial-mesenchymal transition and anoikis in hepatocellular carcinoma using transcriptomics and single-cell sequencing. | Front Cell Dev Biol | 2025 | 40612108 | PubTator, text mining | PubMed |
| Usability Evaluation of Urinary HAI-1, STMN-1 and TN-C in the Diagnosis of Bladder Cancer. | J Clin Med | 2025 | 40507426 | PubTator, text mining | PubMed |
| Multi-omics analysis and single-cell sequencing revealed the lysosome associated molecular subtypes and prognostic model development of papillary thyroid carcinoma. | PLoS One | 2025 | 40493560 | PubTator, text mining | PubMed |
| [New therapeutic approaches in the neoadjuvant/adjuvant treatment of melanoma]. | Dermatologie (Heidelb) | 2025 | 40407846 | PubTator, text mining | PubMed |
| The CD38+HLA-DR+ T cells with activation and exhaustion characteristics as predictors of severity and mortality in COVID-19 patients. | Front Immunol | 2025 | 40370439 | PubTator, text mining | PubMed |
| Single-cell analysis reveals potential therapeutic markers of peripheral blood mononuclear cells from bladder cancer patients. | Braz J Med Biol Res | 2025 | 40367012 | PubTator, text mining | PubMed |
| STAT Signature Dish: Serving Immunity with a Side of Dietary Control. | Biomolecules | 2025 | 40305224 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3925/papers?page=6